A combined proteomic and genetic analysis of the highly variable platelet proteome: From plasmatic proteins and SNPs

Journal of Proteomics

Volumn 75, Issue 18, 2012, Pages 5848-5860

  Veitinger, Michael ^a   Umlauf, Ellen ^a   Baumgartner, Roland ^a   Badrnya, Sigrun ^a   Porter, Jonny ^b   Lamont, John ^b   Gerner, Christopher ^c   Gruber, Christian W ^a   Oehler, Rudolf ^a   Zellner, Maria ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Randox Laboratories Ltd   (United Kingdom)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

2D DIGE; Glutathione S transferase omega 1; Plasma; Platelet proteome; Single nucleotide polymorphism; Variation

Indexed keywords

ALBUMIN; GLUTATHIONE S TRANSFERASE OMEGA 1; GLUTATHIONE TRANSFERASE; HAPTOGLOBIN; UNCLASSIFIED DRUG;

AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC ANALYSIS; GENOTYPE; HUMAN; IN VIVO STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEOMICS; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTE; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; BLOOD PLATELETS; BLOOD PROTEINS; FEMALE; GENE FREQUENCY; GLUTATHIONE TRANSFERASE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEOME; PROTEOMICS; TWO-DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

EID: 84866287797     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2012.07.042     Document Type: Article

References (62)

1. Garcia A. Proteome analysis of signaling cascades in human platelets. Blood Cells Mol Dis Mar. 2006, 36(2):152-156.
2. Zhou A., Zhang F., Chen J.Y. PEPPI: a peptidomic database of human protein isoforms for proteomics experiments. BMC Bioinformatics 2010, 11(Suppl. 6):S7.
3. Uhlen M., Ponten F. Antibody-based proteomics for human tissue profiling. Mol Cell Proteomics Apr. 2005, 4(4):384-393.
4. Harrison P., Wilbourn B., Debili N., Vainchenker W., Breton-Gorius J., Lawrie A.S., et al. Uptake of plasma fibrinogen into the alpha granules of human megakaryocytes and platelets. J Clin Invest Oct. 1989, 84(4):1320-1324.
5. Smyth S.S., McEver R.P., Weyrich A.S., Morrell C.N., Hoffman M.R., Arepally G.M., et al. Platelet functions beyond hemostasis. J Thromb Haemost Nov. 2009, 7(11):1759-1766.
6. Casoli T., Di S.G., Balietti M., Solazzi M., Giorgetti B., Fattoretti P. Peripheral inflammatory biomarkers of Alzheimer's disease: the role of platelets. Biogerontology Oct. 2010, 11(5):627-633.
7. Zellner M., Babeluk R., Jakobsen L.H., Gerner C., Umlauf E., Volf I., et al. A proteomics study reveals a predominant change in MaoB expression in platelets of healthy volunteers after high protein meat diet: relationship to the methylation cycle. J Neural Transm May 2011, 118(5):653-662.
8. Leng T., Liu N., Dai Y., Yu Y., Zhang C., Du R., et al. Dissection of DEN-induced platelet proteome changes reveals the progressively dys-regulated pathways indicative of hepatocarcinogenesis. J Proteome Res Dec. 3 2010, 9(12):6207-6219.
9. Zellner M., Veitinger M., Umlauf E. The role of proteomics in dementia and Alzheimer's disease. Acta Neuropathol Jul. 2009, 118(1):181-195.
10. Winkler W., Zellner M., Diestinger M., Babeluk R., Marchetti M., Goll A., et al. Biological variation of the platelet proteome in the elderly population and its implication for biomarker research. Mol Cell Proteomics Jan. 2008, 7(1):193-203.
11. Whitbread A.K., Masoumi A., Tetlow N., Schmuck E., Coggan M., Board P.G. Characterization of the omega class of glutathione transferases. Methods Enzymol 2005, 401:78-99.
12. Pongstaporn W., Pakakasama S., Sanguansin S., Hongeng S., Petmitr S. Polymorphism of glutathione S-transferase omega gene: association with risk of childhood acute lymphoblastic leukemia. J Cancer Res Clin Oncol May 2009, 135(5):673-678.
13. Marahatta S.B., Punyarit P., Bhudisawasdi V., Paupairoj A., Wongkham S., Petmitr S. Polymorphism of glutathione S-transferase omega gene and risk of cancer. Cancer Lett May 18 2006, 236(2):276-281.
14. McIlwain C.C., Townsend D.M., Tew K.D. Glutathione S-transferase polymorphisms: cancer incidence and therapy. Oncogene Mar. 13 2006, 25(11):1639-1648.
15. Whitbread A.K., Tetlow N., Eyre H.J., Sutherland G.R., Board P.G. Characterization of the human omega class glutathione transferase genes and associated polymorphisms. Pharmacogenetics Mar. 2003, 13(3):131-144.
16. Chung C.J., Pu Y.S., Su C.T., Huang C.Y., Hsueh Y.M. Gene polymorphisms of glutathione S-transferase omega 1 and 2, urinary arsenic methylation profile and urothelial carcinoma. Sci Total Environ Jan. 1 2011, 409(3):465-470.
17. Li Y.J., Oliveira S.A., Xu P., Martin E.R., Stenger J.E., Scherzer C.R., et al. Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease. Hum Mol Genet Dec. 15 2003, 12(24):3259-3267.
18. Kolsch H., Linnebank M., Lutjohann D., Jessen F., Wullner U., Harbrecht U., et al. Polymorphisms in glutathione S-transferase omega-1 and AD, vascular dementia, and stroke. Neurology Dec. 28 2004, 63(12):2255-2260.
19. Wahner A.D., Glatt C.E., Bronstein J.M., Ritz B. Glutathione S-transferase mu, omega, pi, and theta class variants and smoking in Parkinson's disease. Neurosci Lett Feb. 21 2007, 413(3):274-278.
20. Capurso C., Panza F., Seripa D., Frisardi V., Imbimbo B.P., Verdile G., et al. Polymorphisms in glutathione S-transferase omega-1 gene and increased risk of sporadic Alzheimer disease. Rejuvenation Res Dec. 2010, 13(6):645-652.
21. Piacentini S., Polimanti R., Squitti R., Mariani S., Migliore S., Vernieri F., et al. GSTO1*E155del polymorphism associated with increased risk for late-onset Alzheimer's disease: association hypothesis for an uncommon genetic variant. Neurosci Lett Jan. 11 2012, 506(2):203-207.
22. Yanbaeva D.G., Wouters E.F., Dentener M.A., Spruit M.A., Reynaert N.L. Association of glutathione-S-transferase omega haplotypes with susceptibility to chronic obstructive pulmonary disease. Free Radic Res Aug. 2009, 43(8):738-743.
23. Kolsch H., Larionov S., Dedeck O., Orantes M., Birkenmeier G., Griffin W.S., et al. Association of the glutathione S-transferase omega-1 Ala140Asp polymorphism with cerebrovascular atherosclerosis and plaque-associated interleukin-1 alpha expression. Stroke Oct. 2007, 38(10):2847-2850.
24. Hsieh Y.C., Lien L.M., Chung W.T., Hsieh F.I., Hsieh P.F., Wu M.M., et al. Significantly increased risk of carotid atherosclerosis with arsenic exposure and polymorphisms in arsenic metabolism genes. Environ Res Aug. 2011, 111(6):804-810.
25. Zellner M., Winkler W., Hayden H., Diestinger M., Eliasen M., Gesslbauer B., et al. Quantitative validation of different protein precipitation methods in proteome analysis of blood platelets. Electrophoresis Jun. 2005, 26(12):2481-2489.
26. Shevchenko A., Wilm M., Vorm O., Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem Mar. 1 1996, 68(5):850-858.
27. Haudek V.J., Slany A., Gundacker N.C., Wimmer H., Drach J., Gerner C. Proteome maps of the main human peripheral blood constituents. J Proteome Res Aug. 2009, 8(8):3834-3843.
28. Ishihama Y., Oda Y., Tabata T., Sato T., Nagasu T., Rappsilber J., et al. Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol Cell Proteomics Sep. 2005, 4(9):1265-1272.
29. Polimanti R., Piacentini S., Porreca F., Fuciarelli M. Glutathione S-transferase omega class (GSTO) polymorphisms in a sample from Rome (Central Italy). Ann Hum Biol Aug. 2010, 37(4):585-592.
30. Osborne J., Harrison P., Butcher R., Ebsworth N., Tan K. Novel super-high affinity sheep monoclonal antibodies against CEA bind colon and lung adenocarcinoma. Hybridoma Apr. 1999, 18(2):183-191.
31. Blair P., Flaumenhaft R. Platelet alpha-granules: basic biology and clinical correlates. Blood Rev Jul. 2009, 23(4):177-189.
32. Schmuck E., Cappello J., Coggan M., Brew J., Cavanaugh J.A., Blackburn A.C., et al. Deletion of Glu155 causes a deficiency of glutathione transferase omega 1-1 but does not alter sensitivity to arsenic trioxide and other cytotoxic drugs. Int J Biochem Cell Biol 2008, 40(11):2553-2559.
33. Marnell L.L., Garcia-Vargas G.G., Chowdhury U.K., Zakharyan R.A., Walsh B., Avram M.D., et al. Polymorphisms in the human monomethylarsonic acid (MMA V) reductase/hGSTO1 gene and changes in urinary arsenic profiles. Chem Res Toxicol Dec. 2003, 16(12):1507-1513.
34. Yu L., Kalla K., Guthrie E., Vidrine A., Klimecki W.T. Genetic variation in genes associated with arsenic metabolism: glutathione S-transferase omega 1-1 and purine nucleoside phosphorylase polymorphisms in European and indigenous Americans. Environ Health Perspect Aug. 2003, 111(11):1421-1427.
35. Wilkerson W.R., Sane D.C. Aging and thrombosis. Semin Thromb Hemost Dec. 2002, 28(6):555-568.
36. Garcia A., Prabhakar S., Brock C.J., Pearce A.C., Dwek R.A., Watson S.P., et al. Extensive analysis of the human platelet proteome by two-dimensional gel electrophoresis and mass spectrometry. Proteomics Mar. 2004, 4(3):656-668.
37. Corzett T.H., Fodor I.K., Choi M.W., Walsworth V.L., Turteltaub K.W., McCutchen-Maloney S.L., et al. Statistical analysis of variation in the human plasma proteome. J Biomed Biotechnol 2010, 2010:258494.
38. Zhang X., Guo Y., Song Y., Sun W., Yu C., Zhao X., et al. Proteomic analysis of individual variation in normal livers of human beings using difference gel electrophoresis. Proteomics Oct. 2006, 6(19):5260-5268.
39. Fine K.M., Ashbrook P.C., Brigden L.P., Maldonado J.E., Didishelm P. Gel-filtered human platelets. Ultrastructure, function, and role of proteins in inhibition of aggregation by aspirin. Am J Pathol Jul. 1976, 84(1):11-24.
40. Martens L., Muller M., Stephan C., Hamacher M., Reidegeld K.A., Meyer H.E., et al. A comparison of the HUPO Brain Proteome Project pilot with other proteomics studies. Proteomics Sep. 2006, 6(18):5076-5086.
41. Smalley D.M., Root K.E., Cho H., Ross M.M., Ley K. Proteomic discovery of 21 proteins expressed in human plasma-derived but not platelet-derived microparticles. Thromb Haemost Jan. 2007, 97(1):67-80.
42. Piersma S.R., Broxterman H.J., Kapci M., de Haas R.R., Hoekman K., Verheul H.M., et al. Proteomics of the TRAP-induced platelet releasate. J Proteomics Feb. 15 2009, 72(1):91-109.
43. White J.G. The transfer of thorium particles from plasma to platelets and platelet granules. Am J Pathol Oct. 1968, 53(4):567-575.
44. George J.N., Saucerman S. Platelet IgG, IgA, IgM, and albumin: correlation of platelet and plasma concentrations in normal subjects and in patients with ITP or dysproteinemia. Blood Jul. 1988, 72(1):362-365.
45. George J.N. Platelets. Lancet Apr. 29 2000, 355(9214):1531-1539.
46. George J.N. Platelet immunoglobulin G: its significance for the evaluation of thrombocytopenia and for understanding the origin of alpha-granule proteins. Blood Sep. 1 1990, 76(5):859-870.
47. Handagama P., Scarborough R.M., Shuman M.A., Bainton D.F. Endocytosis of fibrinogen into megakaryocyte and platelet alpha-granules is mediated by alpha IIb beta 3 (glycoprotein IIb-IIIa). Blood Jul. 1 1993, 82(1):135-138.
48. Handagama P.J., George J.N., Shuman M.A., McEver R.P., Bainton D.F. Incorporation of a circulating protein into megakaryocyte and platelet granules. Proc Natl Acad Sci U S A Feb. 1987, 84(3):861-865.
49. Handagama P.J., Shuman M.A., Bainton D.F. Incorporation of intravenously injected albumin, immunoglobulin G, and fibrinogen in guinea pig megakaryocyte granules. J Clin Invest Jul. 1989, 84(1):73-82.
50. de Larouziere V., Brouland J.P., Souni F., Drouet L., Cramer E. Inverse immunostaining pattern for synthesized versus endocytosed alpha-granule proteins in human bone marrow megakaryocytes. Br J Haematol Jun. 1998, 101(4):618-625.
51. Anderson N.L., Anderson N.G. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics Nov. 2002, 1(11):845-867.
52. Bugert P., Kluter H. Profiling of gene transcripts in human platelets: an update of the platelet transcriptome. Platelets Nov. 2006, 17(7):503-504.
53. Burillo E., Recalde D., Jarauta E., Fiddyment S., Garcia-Otin A.L., Mateo-Gallego R., et al. Proteomic study of macrophages exposed to oxLDL identifies a CAPG polymorphism associated with carotid atherosclerosis. Atherosclerosis Nov. 2009, 207(1):32-37.
54. Yin Z.L., Dahlstrom J.E., Le Couteur D.G., Board P.G. Immunohistochemistry of omega class glutathione S-transferase in human tissues. J Histochem Cytochem Aug. 2001, 49(8):983-987.
55. Mukherjee B., Salavaggione O.E., Pelleymounter L.L., Moon I., Eckloff B.W., Schaid D.J., et al. Glutathione S-transferase omega 1 and omega 2 pharmacogenomics. Drug Metab Dispos Jul. 2006, 34(7):1237-1246.
56. Zhou H., Brock J., Casarotto M.G., Oakley A.J., Board P.G. Novel folding and stability defects cause a deficiency of human glutathione transferase omega 1. J Biol Chem Feb. 11 2011, 286(6):4271-4279.
57. Taniguchi M., Ayabe T., Ashida T., Fujimoto Y., Kohgo Y. Genetic and phenotypic polymorphisms of the A subunit of coagulation factor XIII in Japanese population. Biochem Genet Oct. 2002, 40(9-10):339-349.
58. de Lange M., Snieder H., Ariens R.A., Spector T.D., Grant P.J. The genetics of haemostasis: a twin study. Lancet Jan. 13 2001, 357(9250):101-105.
59. Marcus K., Moebius J., Meyer H.E. Differential analysis of phosphorylated proteins in resting and thrombin-stimulated human platelets. Anal Bioanal Chem Aug. 2003, 376(7):973-993.
60. Iwabata H., Yoshida M., Komatsu Y. Proteomic analysis of organ-specific post-translational lysine-acetylation and -methylation in mice by use of anti-acetyllysine and -methyllysine mouse monoclonal antibodies. Proteomics Dec. 2005, 5(18):4653-4664.
61. Ma Q., Lu A.Y. Pharmacogenetics, pharmacogenomics, and individualized medicine. Pharmacol Rev Jun. 2011, 63(2):437-459.
62. Josephy P.D. Genetic variations in human glutathione transferase enzymes: significance for pharmacology and toxicology. Hum Genomics Proteomics 2010, 2010:876940.